Basic MR relaxation mechanisms and contrast agent design

Luis M. De Leõn-Rodríguez, André F. Martins, Marco C. Pinho, Neil M. Rofsky, A. Dean Sherry

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The diagnostic capabilities of magnetic resonance imaging (MRI) have undergone continuous and substantial evolution by virtue of hardware and software innovations and the development and implementation of exogenous contrast media. Thirty years since the first MRI contrast agent was approved for clinical use, a reliance on MR contrast media persists, largely to improve image quality with higher contrast resolution and to provide additional functional characterization of normal and abnormal tissues. Further development of MR contrast media is an important component in the quest for continued augmentation of diagnostic capabilities. In this review we detail the many important considerations when pursuing the design and use of MR contrast media. We offer a perspective on the importance of chemical stability, particularly kinetic stability, and how this influences one's thinking about the safety of metal-ligand-based contrast agents. We discuss the mechanisms involved in MR relaxation in the context of probe design strategies. A brief description of currently available contrast agents is accompanied by an in-depth discussion that highlights promising MRI contrast agents in the development of future clinical and research applications. Our intention is to give a diverse audience an improved understanding of the factors involved in developing new types of safe and highly efficient MR contrast agents and, at the same time, provide an appreciation of the insights into physiology and disease that newer types of responsive agents can provide. J. Magn. Reson. Imaging 2015;42:545-565.

Original languageEnglish (US)
Pages (from-to)545-565
Number of pages21
JournalJournal of Magnetic Resonance Imaging
Volume42
Issue number3
DOIs
StatePublished - Sep 1 2015

Fingerprint

Contrast Media
Magnetic Resonance Imaging
Software
Metals
Ligands
Safety
Research

Keywords

  • CEST agents
  • clinical MRI contrast agents
  • gadolinium MRI contrast agents
  • in vivo MRI
  • responsive contrast agents
  • smart contrast agents
  • T<inf>1</inf> and T<inf>2</inf> contrast agents
  • targeted contrast agents
  • thermodynamic and kinetic principles

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Basic MR relaxation mechanisms and contrast agent design. / De Leõn-Rodríguez, Luis M.; Martins, André F.; Pinho, Marco C.; Rofsky, Neil M.; Sherry, A. Dean.

In: Journal of Magnetic Resonance Imaging, Vol. 42, No. 3, 01.09.2015, p. 545-565.

Research output: Contribution to journalArticle

@article{4e46834d9f2d418284349ae8954b6c4a,
title = "Basic MR relaxation mechanisms and contrast agent design",
abstract = "The diagnostic capabilities of magnetic resonance imaging (MRI) have undergone continuous and substantial evolution by virtue of hardware and software innovations and the development and implementation of exogenous contrast media. Thirty years since the first MRI contrast agent was approved for clinical use, a reliance on MR contrast media persists, largely to improve image quality with higher contrast resolution and to provide additional functional characterization of normal and abnormal tissues. Further development of MR contrast media is an important component in the quest for continued augmentation of diagnostic capabilities. In this review we detail the many important considerations when pursuing the design and use of MR contrast media. We offer a perspective on the importance of chemical stability, particularly kinetic stability, and how this influences one's thinking about the safety of metal-ligand-based contrast agents. We discuss the mechanisms involved in MR relaxation in the context of probe design strategies. A brief description of currently available contrast agents is accompanied by an in-depth discussion that highlights promising MRI contrast agents in the development of future clinical and research applications. Our intention is to give a diverse audience an improved understanding of the factors involved in developing new types of safe and highly efficient MR contrast agents and, at the same time, provide an appreciation of the insights into physiology and disease that newer types of responsive agents can provide. J. Magn. Reson. Imaging 2015;42:545-565.",
keywords = "CEST agents, clinical MRI contrast agents, gadolinium MRI contrast agents, in vivo MRI, responsive contrast agents, smart contrast agents, T<inf>1</inf> and T<inf>2</inf> contrast agents, targeted contrast agents, thermodynamic and kinetic principles",
author = "{De Le{\~o}n-Rodr{\'i}guez}, {Luis M.} and Martins, {Andr{\'e} F.} and Pinho, {Marco C.} and Rofsky, {Neil M.} and Sherry, {A. Dean}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/jmri.24787",
language = "English (US)",
volume = "42",
pages = "545--565",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Basic MR relaxation mechanisms and contrast agent design

AU - De Leõn-Rodríguez, Luis M.

AU - Martins, André F.

AU - Pinho, Marco C.

AU - Rofsky, Neil M.

AU - Sherry, A. Dean

PY - 2015/9/1

Y1 - 2015/9/1

N2 - The diagnostic capabilities of magnetic resonance imaging (MRI) have undergone continuous and substantial evolution by virtue of hardware and software innovations and the development and implementation of exogenous contrast media. Thirty years since the first MRI contrast agent was approved for clinical use, a reliance on MR contrast media persists, largely to improve image quality with higher contrast resolution and to provide additional functional characterization of normal and abnormal tissues. Further development of MR contrast media is an important component in the quest for continued augmentation of diagnostic capabilities. In this review we detail the many important considerations when pursuing the design and use of MR contrast media. We offer a perspective on the importance of chemical stability, particularly kinetic stability, and how this influences one's thinking about the safety of metal-ligand-based contrast agents. We discuss the mechanisms involved in MR relaxation in the context of probe design strategies. A brief description of currently available contrast agents is accompanied by an in-depth discussion that highlights promising MRI contrast agents in the development of future clinical and research applications. Our intention is to give a diverse audience an improved understanding of the factors involved in developing new types of safe and highly efficient MR contrast agents and, at the same time, provide an appreciation of the insights into physiology and disease that newer types of responsive agents can provide. J. Magn. Reson. Imaging 2015;42:545-565.

AB - The diagnostic capabilities of magnetic resonance imaging (MRI) have undergone continuous and substantial evolution by virtue of hardware and software innovations and the development and implementation of exogenous contrast media. Thirty years since the first MRI contrast agent was approved for clinical use, a reliance on MR contrast media persists, largely to improve image quality with higher contrast resolution and to provide additional functional characterization of normal and abnormal tissues. Further development of MR contrast media is an important component in the quest for continued augmentation of diagnostic capabilities. In this review we detail the many important considerations when pursuing the design and use of MR contrast media. We offer a perspective on the importance of chemical stability, particularly kinetic stability, and how this influences one's thinking about the safety of metal-ligand-based contrast agents. We discuss the mechanisms involved in MR relaxation in the context of probe design strategies. A brief description of currently available contrast agents is accompanied by an in-depth discussion that highlights promising MRI contrast agents in the development of future clinical and research applications. Our intention is to give a diverse audience an improved understanding of the factors involved in developing new types of safe and highly efficient MR contrast agents and, at the same time, provide an appreciation of the insights into physiology and disease that newer types of responsive agents can provide. J. Magn. Reson. Imaging 2015;42:545-565.

KW - CEST agents

KW - clinical MRI contrast agents

KW - gadolinium MRI contrast agents

KW - in vivo MRI

KW - responsive contrast agents

KW - smart contrast agents

KW - T<inf>1</inf> and T<inf>2</inf> contrast agents

KW - targeted contrast agents

KW - thermodynamic and kinetic principles

UR - http://www.scopus.com/inward/record.url?scp=84939160529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939160529&partnerID=8YFLogxK

U2 - 10.1002/jmri.24787

DO - 10.1002/jmri.24787

M3 - Article

C2 - 25975847

AN - SCOPUS:84939160529

VL - 42

SP - 545

EP - 565

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 3

ER -